ES2031930T3 - Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo. - Google Patents

Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.

Info

Publication number
ES2031930T3
ES2031930T3 ES198888100385T ES88100385T ES2031930T3 ES 2031930 T3 ES2031930 T3 ES 2031930T3 ES 198888100385 T ES198888100385 T ES 198888100385T ES 88100385 T ES88100385 T ES 88100385T ES 2031930 T3 ES2031930 T3 ES 2031930T3
Authority
ES
Spain
Prior art keywords
active ingredient
aspoxicillin
preparation containing
lyophilized preparation
aspoxicilina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888100385T
Other languages
English (en)
Spanish (es)
Inventor
Keiichi Kohno
Hiroshi Miura
Yoshiyuki Hirakawa
Toshiyuki Ueki
Seiichi Morikuni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2031930T3 publication Critical patent/ES2031930T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES198888100385T 1987-01-14 1988-01-13 Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo. Expired - Lifetime ES2031930T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62006868A JPS63174927A (ja) 1987-01-14 1987-01-14 抗菌性凍結乾燥製剤

Publications (1)

Publication Number Publication Date
ES2031930T3 true ES2031930T3 (es) 1993-01-01

Family

ID=11650214

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888100385T Expired - Lifetime ES2031930T3 (es) 1987-01-14 1988-01-13 Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.

Country Status (18)

Country Link
US (1) US4966899A (en, 2012)
EP (1) EP0278243B1 (en, 2012)
JP (1) JPS63174927A (en, 2012)
KR (1) KR930001830B1 (en, 2012)
CN (1) CN1024754C (en, 2012)
AT (1) ATE61222T1 (en, 2012)
AU (1) AU597463B2 (en, 2012)
CA (1) CA1308358C (en, 2012)
DE (1) DE3861866D1 (en, 2012)
DK (1) DK15088A (en, 2012)
ES (1) ES2031930T3 (en, 2012)
FI (1) FI89454C (en, 2012)
GR (1) GR3001565T3 (en, 2012)
HK (1) HK63592A (en, 2012)
HU (1) HU197985B (en, 2012)
IE (1) IE60049B1 (en, 2012)
IL (1) IL85031A (en, 2012)
SG (1) SG60292G (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68912270T2 (de) * 1988-11-01 1994-04-28 Sanol Arznei Schwarz Gmbh Lyophilisiertes MDM enthaltende Zusammensetzung und Verfahren zu deren Herstellung.
CN1048248C (zh) * 1994-05-02 2000-01-12 盐野义制药株式会社 吡咯烷基硫基碳代青霉烯衍生物的结晶、含该结晶的冷冻干燥制剂及其制造方法
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
CN102372727A (zh) * 2010-08-10 2012-03-14 海南美好西林生物制药有限公司 一种阿扑西林钠的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733404A (en) * 1970-09-04 1973-05-15 Squibb & Sons Inc Antibacterial composition containing alpha-aminobenzyl penicillins
US4053609A (en) * 1975-09-12 1977-10-11 Tanabe Seiyaku Co., Ltd. Penicillins and processes for preparing the same
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
GB1539510A (en) * 1976-08-23 1979-01-31 Beecham Group Ltd Injectable compositions
JPS5640686A (en) * 1979-09-11 1981-04-16 Tanabe Seiyaku Co Ltd Purification of penicillin derivative
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof

Also Published As

Publication number Publication date
JPS63174927A (ja) 1988-07-19
KR930001830B1 (ko) 1993-03-15
EP0278243A1 (en) 1988-08-17
HUT46212A (en) 1988-10-28
CN1034131A (zh) 1989-07-26
FI89454C (fi) 1993-10-11
EP0278243B1 (en) 1991-03-06
IE60049B1 (en) 1994-05-18
US4966899A (en) 1990-10-30
IE880049L (en) 1988-07-14
HU197985B (en) 1989-07-28
AU1022688A (en) 1988-07-21
DE3861866D1 (de) 1991-04-11
SG60292G (en) 1992-09-04
DK15088D0 (da) 1988-01-13
HK63592A (en) 1992-08-28
CA1308358C (en) 1992-10-06
ATE61222T1 (de) 1991-03-15
FI880027A0 (fi) 1988-01-06
JPH053847B2 (en, 2012) 1993-01-18
KR880008812A (ko) 1988-09-13
AU597463B2 (en) 1990-05-31
IL85031A (en) 1992-07-15
DK15088A (da) 1988-07-15
CN1024754C (zh) 1994-06-01
GR3001565T3 (en) 1992-11-23
FI89454B (fi) 1993-06-30
FI880027L (fi) 1988-07-15

Similar Documents

Publication Publication Date Title
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
MX9207402A (es) Dispositivo osmotico para surtir un agente benefico a la cavidad oral.
GR3007202T3 (en, 2012)
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
FI886019A7 (fi) Laastari vaikuttavien aineiden valvotusti jakamiseksi iholle
ES8706581A1 (es) Un metodo para preparar un dispositivo biomedico conformado
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
EP0270026A3 (en) Pharmaceutical preparation comprising vitamin b6
ES2031930T3 (es) Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.
AU5643299A (en) Humic acid and its use in the treatment of various conditions
DK137589A (da) Salicylsyreholdigt middel til behandling af hudsygdomme
Moyer Some effects of 0.5 per cent silver nitrate and high humidity upon the illness associated with large burns
FI914939A0 (fi) Preparat foer nagel-, hud- och haorvaord.
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
MY100892A (en) Veterinary preparations.
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
RU93016030A (ru) Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
Juca et al. Antimicrobial therapy with cefoxitin sodium in vascular surgery and angiology: Clinical and laboratorial survey.
Hayat < The> level of antiepileptic drug [Dilantin] in saliva and gingival tissue and its relationship to gingival Hyperplasia
Mordenti COMBINATION ANTIBIOTIC THERAPY: COMPARISON OF CONSTANT INFUSION AND INTERMITTENT BOLUS DOSING IN AN IN VITRO KINETIC MODEL AND AN EXPERIMENTAL ANIMAL MODEL.
SU1020128A1 (ru) Средство дл обработки гн т перед подсадкой их к овцематкам
RU94032102A (ru) Способ лечения или облегчения боли, связанной со скелетно-мышечными, нервными или кожными заболеваниями, препараты на основе хлорида цезия, способ получения терапевтических препаратов, способ анестезирования

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278243

Country of ref document: ES